DERM
Journey Medical Corporation
$4.95
$0.00(0.00%)
39
Overall
40
Value
36
Tech
42
Quality
Market Cap
$228.18M
Volume
292.99K
52W Range
$4.31 - $9.56
Target Price
$13.25
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $63.1M | $71.0M | $59.7M | $55.1M | ||
| Total Revenue | $63.1M | $73.7M | $79.2M | $56.1M | ||
| COST OF GOODS SOLD | ||||||
| Cost of Revenue | $32.1M | $30.8M | $22.9M | $20.9M | ||
| GROSS PROFIT | ||||||
| Gross Profit | $31.1M | $42.9M | $56.3M | $35.3M | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $74.7M | $70.4M | $55.2M | $53.5M | ||
| Research & Development | $2.7M | $10.9M | $7.5M | $9.9M | ||
| Research Expense | $2.7M | $10.9M | $7.5M | $9.9M | ||
| Selling, General & Administrative | $71.9M | $59.5M | $43.9M | $40.2M | ||
| General & Administrative Expenses | $71.9M | $59.5M | $43.9M | $40.2M | ||
| Salaries & Wages | -- | -- | $2.6M | $6.1M | ||
| Depreciation & Amortization | -- | -- | $3.8M | $3.4M | ||
| Depreciation & Amortization | -- | -- | $3.8M | $3.4M | ||
| Amortization | $2.5M | $4.3M | $3.8M | $3.4M | ||
| Other Operating Expenses | $93.0K | $97.0K | $81.3M | $69.8M | ||
| OPERATING INCOME | ||||||
| Operating income | $-34.9M | $-27.5M | $-2.1M | $-13.7M | ||
| EBITDA | $-30.2M | $-23.1M | $579.0K | $-8.5M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $7.0M | $2.0M | $1.7M | $2.7M | ||
| Net Non-Operating Interest Income/Expense | $-7.0M | $-2.0M | $-500.0K | $-600.0K | ||
| Gain on Sale of Securities | $-447.0K | -- | -- | -- | ||
| Other Income/Expense | $449.0K | $-2.6M | $-16.4M | $-2.1M | ||
| Other Special Charges | $-2.0K | $2.6M | $19.5M | $2.1M | ||
| SPECIAL ITEMS | ||||||
| Restructring And Mn A Income | -- | $-20.0M | $-5.0M | -- | ||
| Special Income Charges | $-32.1M | $20.0M | $5.0M | -- | ||
| Other Impairment Of Capital Assets | -- | -- | $3.1M | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-35.3M | $-27.5M | $-3.6M | $-11.9M | ||
| Pre-Tax Income | $-42.4M | $-29.6M | $-3.6M | $-14.6M | ||
| INCOME TAX | ||||||
| Tax Provision | $1.6M | $63.0K | $221.0K | $61.0K | ||
| NET INCOME | ||||||
| Net Income | $-44.0M | $-29.6M | $-3.9M | $-14.7M | ||
| Net Income (Continuing Operations) | $-44.0M | $-29.6M | $-3.9M | $-14.7M | ||
| Net Income (Discontinued Operations) | $-44.0M | $-29.6M | $-3.9M | $-14.7M | ||
| Net Income (Common Stockholders) | $2.7M | $-29.7M | $-3.9M | $-14.7M | ||
| TOTALS | ||||||
| Total Expenses | $106.7M | $101.2M | $78.1M | $74.4M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $10.2M | $17.5M | $18.2M | $20.4M | ||
| Average Shares Outstanding (Diluted) | $10.2M | $17.5M | $18.3M | $20.4M | ||
| Shares Outstanding | $17.3M | $17.8M | $19.9M | $23.1M | ||
| Basic EPS | $-4.32 | $-1.69 | $-0.21 | $-0.72 | ||
| Basic EPS (Continuing Operations) | $-4.32 | $-1.69 | $-0.21 | $-0.72 | ||
| Diluted EPS | $-4.32 | $-1.69 | $-0.21 | $-0.72 | ||
| Diluted EPS (Continuing Operations) | $-4.32 | $-1.69 | $-0.21 | $-0.72 | ||
| OTHER METRICS | ||||||
| Earnings from equity interest | $-820.0K | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $-820.0K | -- | -- | -- | ||
| Excise Taxes | -- | $30.8M | -- | -- | ||
| Other Gand A | $71.9M | $59.5M | $43.9M | $40.2M | ||
| Write Off | $32.1M | -- | -- | -- | ||
| Restruct | -- | $-20.0M | $-5.0M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DERM | $4.95 | 0% | 292.99K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Journey Medical Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW